The uptake of different surfactant lipids: dipalmitoylphosphatidylcholine (DPPC), phosphatidylglycerol (PG) or phosphatidylinositol (PI) and liposomes with a surfactant-like composition by alveolar type II cells (alveolar type II cells) and macrophages (alveolar macrophages) was studied in vitro.
Introduction
The alveolus is lined with a thin layer of lipids and proteins, called surfactant and this surface active agent has an essential role in maintaining normal lung function. Pulmonary surfactant is produced by alveolar type II cells . By weight, approximately 90% of surfactant consists of lipids. Although, the lipid composition varies in different species, its major component is phosphatidylcholine (PC; 70-80%) of which nearly 50% is saturated dipalmitoylphosphatidylcholine (DPPC). DPPC is the major surface tensionreducing component of surfactant. In addition, surfactant contains variable amounts of phosphatidylglycerol (PG; 7-18%), phosphatitylinositol (PI; 2-4%) and phosphatidylethanolamine (PE; 2-3%) (1) . The remaining percentage consists of other phospholipids and cholesterol (1) .
The presence of surfactant within the alveolus is the result of a complex system of production, secretion, uptake and recycling. The production of newly synthesized surfactant has been suggested to be relatively slow, especially in newborn animals (2, 3) . Therefore, inactivated surfactant is reutilized, i.e. recycled. It has been demonstrated that 50-90% of the PC is recycled depending on age and species, where with an increasing age the contribution of recycling decreases (4) . Inactivated surfactant is cleared from the alveolar space mainly by alveolar type II cells (5) . This uptake of surfactant by alveolar type II cells is essential to enable recycling of surfactant. Therefore uptake or reuptake of surfactant plays an important role in the homeostasis of the surfactant metabolism.
It has been shown that there are essential differences in the composition of surfactant between neonates and adults regarding the phospholipids which, combined with the fact that neonates rely more on recycling, suggests an effect of the composition on the uptake of surfactant. Previous studies have demonstrated an effect of surfactant proteins, especially SP-A, on the uptake by alveolar cells (6) (7) (8) (9) . However, little is known on the effect of lipid composition on the clearance of surfactant from the alveolar space by alveolar cells, since most studies have focused on internalization of DPPC by both alveolar type II cells and alveolar macrophages. Quintero et al. have shown a more rapid clearance of PG by alveolar macrophages in contrast to DPPC (10) , indicating an effect of the lipid composition on the uptake. It remains unclear, however, whether the uptake of surfactant by alveolar type II cells is also affected by lipid composition. Therefore, we studied the uptake of the major surfactant lipids by alveolar type II cells as well as alveolar macrophages using fluorescent labeled liposomes (11) . In addition, we examined how the different lipids influence each other's uptake by alveolar cells.
Material & methods

Ethical Guidelines
This study was approved by the Institutional Animal Committee at the Erasmus University Rotterdam and complied with NIH guidelines. A total of 30 male Sprague Dawley rats (IFFA Credo, The Netherlands) with an average weight of 280 ± 41 g were used.
Materials
Dipalmitoylphosphatidylcholine (DPPC), egg phosphatidylcholine (PC), phosphatidylglycerol (PG), phosphatidylinositol (PI), phosphatidylethanolamine (PE) and cholesterol were purchased from Sigma (Zwijndrecht, The Netherlands). PE labeled with Bodipy® and PE labeled with Texas Red® were obtained from Molecular Probes (Leiden, The Netherlands). Both labeled PE lipids are labeled in the head-group.
Liposome preparation
To prepare liposomes, the indicated concentrations of the different lipids were mixed. The mixture of lipids was dried under a stream of nitrogen gas. The liposomes were suspended in PBS at a concentration of 0.25 mg lipids/ml using glass pearls and vortexing. Immediately prior to use, the liposome suspension was sonicated for 2 min on ice using an ultrasonic disintegrator (Branson Sonifier 250, Danbury, USA) to prepare small unilamellar liposomes (11) . The size of the liposomes was determined by dynamic light scattering at 25 °C with a Malvern 4700 system using a 25 mW He-Ne laser (NEC, Tokyo, Japan) and the automeasure version 3.2 software (Malvern Ltd, UK). As a measure of particle size distribution of the dispersion, the system reports a polydispersity index (p.d.). This index ranges from 0.0 for a monodisperse and up to 1.0 for an entirely polydisperse dispersion. After ultrasonification the liposomes size ranged from 140 to 165 nm and the polydispersity indexe ranged from 0.2 to 0.35.
Isolation of alveolar cells
Prior to isolation of the cells, the thorax was opened and the blood cells were removed from the lungs by perfusing the pulmonary artery with saline (37 0 C) supplemented with 20 IE heparin (Leo Pharma, Weesp,
The Netherlands). The lungs were removed from the thoracic cavity en bloc and lavaged with 10 ml of 
Uptake of liposomes by alveolar cells
Alveolar type II cells and alveolar macrophages were isolated as described above and were suspended in solution 2 to a concentration of 2x10 6 cells/ml. A total of 3x10 5 cells were incubated with various concentrations of the different liposomes at 37 0 C (unless stated otherwise) (final volume 500 µl) in a shaking water bath. After 1 hour, the incubation was terminated by addition of 2 ml of ice-cold PBS (11).
The cell suspension was centrifuged at 100x g for 10 min at 4 0 C. The supernatant was removed and the cells were suspended in 2 ml of ice-cold PBS and centrifuged again. This wash procedure was repeated twice. Finally, the pellet was resuspended in 200 µl cold PBS and cell-associated fluorescence was determined as described below.
Flow cytometry
As a measure for the amount of internalized liposomes, cell-associated fluorescence of a total of 15,000 alveolar type II cells or alveolar macrophages was determined using flow cytometry (FACSCalibur; Becton Dickinson; Mountain View, USA). The Bodipy® fluorescence was determined in the FL 1 channel whereas the Texas Red ® fluorescence was determined in the FL 4 channel. The spill-over of Bodipy in the FL 4 channel as well as Texas Red in the FL 1 channel, was less than 1% and was not corrected for in the double labeling experiments. Control alveolar macrophages and alveolar type II cells were used in each experiment to determine the autofluorescence of the cells. Subsequently, the mean cell-associated fluorescence was determined only for those cells that had a higher fluorescence than that caused by autofluorescence (gated cells) (11) . Cells with a higher fluorescence than that caused by auto-fluorescence were collected and identified using the methods described above, showing similar results for all types of liposomes, 81 ± 6% of the cells were type II cells within the type II cell isolate and 93 ± 5% were alveolar macrophages in the alveolar macrophage isolate.
Localization of cell-associated fluorescence
Confocal laser miscoscopy was performed using a Zeiss LSM 410, with standard objectives and photomultiplier tubes dedicated to the appropriate excitation and emission spectra of the used fluorescent label (Bodipy excitation 503 nm emission 512 nm, Texas Red excitation 589 nm emission 615 nm).
Images were serial sectioned at a depth of 0.5 µm to distinguish cell-membrane associated fluorescence from true intracellular fluorescence.
Statistical analysis
The differences in uptake of different components were analyzed using an ANOVA followed by a Bonferroni post hoc test.
Differences were considered statistically significant at a p <0.05. Values are expressed as mean ± SEM
Results
Concentration dependent uptake of liposomes
To study the uptake of the phospholipid components of surfactant, DPPC, PC, PG and PI, isolated alveolar cells were incubated for 1 hour with liposomes of different compositions. The mean cell-associated fluorescence, as a measurement for uptake of liposomes, of the alveolar type II cells and alveolar macrophages demonstrates a concentration-dependent increase. With exception of the uptake of PI liposomes by alveolar macrophages and the uptake of PG liposomes by alveolar type II cells, the uptake of all individual liposomes reaches an apparent maximum at 25 µg/ml (Fig. 1A, B) . However, the maximum cell-associated fluorescence, e.g. maximal uptake, at the plateau differs between the various liposome compositions.
The 86% PG and 86% PI liposomes are internalized significantly more by alveolar type II cells than normal liposomes (PC, DPPC, PG, PI, PE and cholesterol in weight ratio of 21:55:8:2:6:8). The uptake of 86% PC liposomes and 86% DPPC liposomes does not differ from the normal liposomes, except at a higher lipid concentration of 50 µg/ml, more 86% PC liposomes are internalized ( Fig 1A) .
There is a significant difference in the uptake of 86% PG liposomes, 86% PI, 86% PC, and normal liposomes by alveolar macrophages at a concentration of 50 µg/ml. The internalization of 86% PG liposomes is significantly higher than that of normal liposomes whereas the uptake of 86% DPPC liposomes by alveolar macrophages is significantly lower than normal liposomes. These results may indicate that uptake of liposomes by alveolar macrophages and alveolar type II is effected by the charge of the liposomes (i.e. 86% PG and 86% PI liposomes are more negatively charged).
Percentage alveolar type II cells and alveolar macrophages involved in the uptake.
The percentage gated alveolar type II cells and alveolar macrophages involved in the uptake of liposomes also demonstrate a concentration-dependent increase, reaching a plateau for all groups of liposomes ( at a concentration of 50 µg/ml ( Fig. 2A) .
Localization of cell-associated fluorescence
To ascertain that the cell-associated fluorescence was located within the cell rather than aspecific binding to the outer membrane of the cell, confocal laser microscopy was used. The confocal scans through the middle of the cell show a punctuate fluorescence throughout the cell limited to its circumference with the exception of its nucleus. Both labels, the TexasRed-labeled PG liposomes (Fig. 3 A,C) and Bodipy-labeled DPPC liposomes ( Fig. 3 (Fig 4 A, B ).
In addition, when the concentration of 86% PG liposomes is increased, significantly less cells take up preferentially 86% PI liposomes; there is a significant increase in alveolar cells, either alveolar type II cells or alveolar macrophages, that take up both 86% PI liposomes and 86% PG liposomes (Fig. 5A, B ). There are hardly any alveolar cells that internalize only 86% PG liposomes, except at the highest PG concentration, 50 µg/ml, where there is a significant percentage (3%) of the alveolar type II cells that internalize only 86% PG liposomes. The total amount of alveolar cells involved in the uptake does not change significantly (83% for alveolar macrophages and 79% for alveolar type II cells) (Fig 5A, B) . These results may indicate that both types of liposomes are taken up via the same pathway. Next, the question rose whether this pathway was the same for DPPC. Bodipy-associated mean fluorescence (Fig. 6A, B) .
Effect of 86% PG Texas
Raising the concentration of 86% PG liposomes results in a significant increase in double labeled alveolar macrophages, together with a significant decrease in Bodipy labeled alveolar macrophages.
At a concentration of 12.5 µg/ml 86% PG liposomes, the amount of double labeled alveolar macrophages decreases again and the amount of alveolar macrophages that take up only 86% PG liposomes increases (Fig. 7B) . The alveolar type II cells demonstrate a similar change in cells involved in the uptake, first the amount of double labeled cells increase, and at a concentration of 5 µg/ml, which is lower than for alveolar macrophages, the amount of double alveolar type II cells decreases, together with an increase in alveolar type II cells that take up only 86% PG liposomes (Fig 7A) . 
Effect of 86% DPPC Texas
Discussion
In the current study we investigated the uptake of the main phospholipid components of surfactant in vitro by alveolar type II cells and alveolar macrophages. We used fluorescent labeled liposomes containing 86% of the studied component, 8% cholesterol and 6% labeled phosphatidylethanolamine. Confocal laser microscopy demonstrated the intracellular presence of cell-associated fluorescence, indicating that the fluorescent labeled liposomes are indeed taken up by the alveolar cells (Fig. 3) . The uptake of the liposomes shows a concentration-dependent increase in cell-associated fluorescence (Fig. 1) , reaching a plateau at 25 µg/ml, similar to the results of our previous study (11) . The uptake of the more negatively charged liposomes, i.e. 86% PG and 86% PI liposomes, by alveolar type II cells and alveolar macrophages is significantly higher than that of the more neutrally charged liposomes, i.e. 86% PC, 86% DPPC and normal liposomes. These results indicate that the alveolar cells have a higher affinity for negatively charged liposomes.
The mechanism of internalization of liposomes by the alveolar cells is not clear at the moment. For macrophages as well as alveolar type II cells at least part of the uptake of liposomes seems to be mediated by the coated-pit pathway (14-16), suggesting a receptor-mediated process, but for which the receptor and the specificity of the receptor are unknown. For arguments sake we assume that the uptake of liposomes by alveolar cells is receptor mediated. A receptor with a high affinity for negatively charged liposomes per se and which does not discriminate between PG and PI liposomes, as was shown by competition experiments with 86% PI and 86% PG containing liposomes.
The receptor is not specific for negatively charged liposomes. The competition experiments of PG and DPPC liposomes demonstrate that the uptake of DPPC by the alveolar cells can be fully blocked by PG leading to uptake of PG instead, whereas the other way around, competing PG with DPPC, leads to only a partial reduction in the PG uptake by alveolar cells (Table 1) . Therefore the receptor affinities for DPPC and PG and/or PI liposomes seem to differ; the highest affinity being for PG followed by PI and DPPC.
There seems to be very few differences in the uptake of phospholipids by alveolar macrophages and alveolar type II cells, but from our experiments it can not be concluded that the "phospholipid receptor" of Up to now, the focus has been on the role of the surfactant proteins in the uptake of DPPC by alveolar cells in vitro. At least three of the four surfactant proteins, SP-A, SP-B and SP-C, were implicated in the internalization of surfactant lipids by alveolar cells. SP-A and SP-C were shown to stimulate the uptake of liposomes by alveolar cells (6-9, 16, 17) , whereas the influence of SP-B on the uptake of liposomes is more complex. SP-B was reported to stimulate the uptake by alveolar cells (18) (19) (20) , whereas others have shown that SP-B can inhibit the SP-C mediated uptake by alveolar type II cells (7, 8) . In vivo the role of the surfactant proteins becomes more complex and unclear. In SP-A knock out mice the uptake of surfactant by alveolar cells appears to be normal (21, 22) , whereas one would expect that based on the vitro results the uptake would be disturbed in these animals, only under inflammatory conditions are differences in lipid uptake between SP-A (+/+) and SP-A (-/-) mice observed (23) . In contrast, for SP-D no influence on lipid uptake could be demonstrated in vitro (17) , while the surfactant lipid metabolism in SP-D (-/-) mice was disturbed (24, 25) . Therefore, in spite of numerous studies, the role of the surfactant proteins in the surfactant lipid metabolism in vivo still needs to be further clarified.
The influence of the surfactant phospholipid composition, in particular the charge of the phospholipids, on the uptake of surfactant liposomes by alveolar cells is also not clear. The first data are derived from in vivo experiments by Jacobs et al. (26, 27) , demonstrating the disappearance of radiolabeled PG in the lungs of neonatal and adult rabbits after intratracheal injection. Bates and Chandler have shown that radiolabeled PG containing vesicles are internalized more rapidly by alveolar type II cells in vitro (28, 29) . Recently, a study by Quintero et al. indicated that alveolar macrophages internalize PG more readily than DPPC in vitro (10) . The present study indicates that, besides alveolar macrophages, also alveolar type II cells have a higher affinity for PG or PI containing liposomes than for the more neutrally charged liposomes. In addition, the pathway of uptake of PG, PI, and DPPC by alveolar cells appears to be the same. Uptake of surfactant lipids by alveolar cells is an important step in the recycling of surfactant. Surfactant recycling itself is crucial to maintain normal lung functions. Therefore, changes in the surfactant lipid composition, for instance, more or less PG or other negatively charged lipids, may not only alter the uptake of these lipids but also of DPPC, the most important surface tension lowering component of surfactant. In various diseases, such as respiratory distress syndrome (RDS), extrinsic allergic alveolites and respiratory infections changes in the surfactant lipid composition were observed (30, 31) . Whether an altered uptake of surfactant lipids by alveolar cells plays a role in the pathogenesis of respiratory diseases is not yet known.
Further studies on the role of the surfactant lipid composition on the uptake of surfactant by alveolar cells are therefore warranted. In particular, the influence of the lipid composition on the in vivo uptake of surfactant and the effects on lung mechanics. Not only will this information expand our knowledge on the surfactant metabolism but it might also provide new tools for therapeutic interventions for various respiratory diseases. 
